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Abstract— Home hospitalization (HH) is presented as a
healthcare alternative capable of providing high standards of
care when patients no longer need hospital facilities. Although
HH seems to lower healthcare costs by shortening hospital stays
and improving patient’s quality of life, the lack of continuous
observation at home may lead to complications in some patients.
Since blood tests have been proven to provide relevant prognosis
information in many diseases, this paper analyzes the impact of
different sampling methods on the prediction of HH outcomes.
After a first exploratory analysis, some variables extracted
from routine blood tests performed at the moment of HH
admission, such as hemoglobin, lymphocytes or creatinine, were
found to unmask statistically significant differences between
patients undergoing successful and unsucessful HH stays. Then,
predictive models were built with these data, in order to identify
unsuccessful cases eventually needing hospital facilities. How-
ever, since these hospital admissions during HH programs are
rare, their identification through conventional machine-learning
approaches is challenging. Thus, several sampling strategies
designed to face class imbalance were herein overviewed and
compared. Among the analyzed approaches, over-sampling
strategies, such as ROSE (Random Over-Sampling Examples)
and conventional random over-sampling, showed the best
performances. Nevertheless, further improvements should be
proposed in the future so as to better identify those patients
not benefiting from HH.
I. INTRODUCTION
Home hospitalization (HH) emerged in response to the
growing demand for hospital care and the high costs as-
sociated with the diagnosis and treatment of acute and
chronic decompensated diseases. This healthcare alternative
is capable of providing high standards of care through a set
of home-based medical and nursing services, when patients
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no longer need hospital facilities, but still require active
and complex surveillance. Indeed, HH has demonstrated
to lower healthcare-associated costs by shortening hospital
stays and avoiding readmissions; and it has been presented
as an opportunity to improve integrated care [1], [2], [3].
Moreover, it reduces the risk of nosocomial infections, and
it has been reported to improve patient’s quality of life, by
extending stays in a familiar environment [5], [6].
However, some relevant disease-related early signs may
not be detected due to the lack of continuous observation at
home, leading to complications that may result in regular
hospital admissions. Thus, eligibility criteria in order to
identify those patients who may not benefit from HH is of
major importance. Since blood test data has proven to be a
significant indicator of prognosis in many diseases [7], [8],
[9], we hypothesized that those patients not being eligible
for HH programs could be identified through routine blood
tests, performed at the moment of admission.
Nevertheless, unsuccessful HH cases are rare. Since most
conventional machine-learning approaches are extremely
sensitive to class imbalance, they show a strong bias toward
the majority class (far superior in number). To tackle this lim-
itation, a number of sampling strategies have been developed,
but their suitability is generally problem-dependent. Thus,
after an exploratory statistical analysis of the available data
to evaluate its potential to distinguish between successful and
unsuccessful HH stays, this paper provides an overview of
different sampling strategies and compares their impact on
classification performance, in this particular scenario.
II. MATERIALS AND METHODS
A. Study population
The blood test data from 1951 patients having been
admitted to the HH program delivered by the Integrated Care
Unit at Hospital Clı´nic de Barcelona (Spain) was collected
in the context of a prospective study conducted from January
2012 to December 2015, including the following variables:
• L1300: Leukocyte count (109/L), [4.00− 11.00]
• L1301: Platelet count (109/L), [130− 400]
• L1302: Mean platelet volume (fl), [6.2− 11.0]
• L1305: Red blood cell count (1012/L), [3.90− 5.50]
• L1306: Neutrophils (%), [45.0− 75.0]
• L1307: Abs. neutrophils (109/L), [2.5− 7.0]
• L1308: Lymphocytes (%), [17.0− 55.0]
• L1309: Abs. lymphocytes (109/L), [0.9− 4.5]
• L1310: Monocytes (%), [2.0− 10.0]
• L1311: Abs. monocytes (109/L), [0.1− 1.0]
• L1312: Eosinophils (%), [< 5.0]
• L1313: Abs. eosinophils (109/L), [< 0.5]
• L1314: Hemoglobin concentration (g/L), [120.0−170.0]
• L1315: Basophils (%), [< 2.0]
• L1316: Abs. basophils (109/L), [< 0.2]
• L1319: Hematocrit (L/L), [0.36− 0.51]
• L1320: Mean corpuscular volume (fl), [80.0− 100.0]
• L1321: Mean corpuscular hemoglobin (pg), [26.7 −
33.3]
• L1322: Mean corpuscular hemoglobin concentration
(g/L), [310− 350]
• L1323: Red cell distribution width (%), [10.5− 17.2]
• L2422: Glucose (mg/dL), [65− 110]
• L2467: Creatinine (mg/dL), [0.30− 1.30]
• L2507: Sodium (mEq/L), [135− 145]
• L2508: Potassium (mEq/L), [3.5− 5.5]
The study protocol was approved by the Ethical Commit-
tee for Human Research at Hospital Clı´nic and all patients
signed a written informed consent before paticipation. Par-
ticipants ages ranged between 16 and 105 (70.75 ± 15.00)
years old and 62% were males. From 1951 patients being
firstly admitted to the HH program, 101 were eventually
transferred to regular hospitalization due to complications of
heterogeneous origin (unsuccessful group). The remaining
1850 patients were discharged after a successful HH stay
(successful group). Table I summarizes the baseline charac-
teristics of both study groups, showing a significantly higher
proportion of cardiovascular unsuccessful patients.
TABLE I
CLINICAL CHARACTERISTICS OF SUCCESSFUL AND UNSUCCESSFUL
CASES, BASED ON THEIR NEED FOR REGULAR CARE SERVICES.
Successful Unsuccessful p-value
(n=1850) (n=101)
Age, years old 70.6 ± 15.0 72.9 ± 14.7 0.072
Male sex, n (%) 1153 (62.3%) 66 (65.3%) 0.613
Main diagnosis, n (%)
Cardiology 196 (10.6%) 26 (25.7%) <0.001
Respiratory 573 (31.0%) 24 (23.8%) 0.156
Oncology 146 (7.9%) 8 (7.9%) 1.000
Surgery 366 (19.8%) 15 (14.9%) 0.276
Acute 569 (30.8%) 28 (27.7%) 0.594
Values are mean ± standard deviation or number of observations (%).
B. Statistical analysis
In order to analyze the discriminant potential of blood test
data and identify those variables being more susceptible of
having a relevant impact on classification, we performed a
first exploratory analysis where each variable was compared
between successful and unsuccessful cases, by means of
Mann-Whitney U non-parametric tests, setting the level of
significance at α = 0.05. Nevertheless, all variables were
then taken into account for the classification approach herein
proposed. Data redundancy was also evaluated by quantify-
ing correlations between pairs of variables.
C. Class balancing
Data were divided in the training (Ntr = 1464, 75%
randomly selected patients) and testing (Nts = 487) subsets.
While sampling and model training were only applied to this
randomly selected training subset, the remaining 25% of data
were then used for classification performance quantification.
It is to note that data partitioning was performed with a
stratified strategy, so as to ensure that both training and
testing subsets contained a similar proportion of samples
from each class as the original dataset.
Sampling methods have become standard approaches for
improving classification performance in the context of imbal-
anced datasets [10]. They modify the training subset to create
a more balanced class distribution that allows classifiers to
better capture the decision boundary between majority and
minority classes. The resulting (sampled) dataset represents
an estimation of the original data, containing instances from
the same (or similar) distribution. In this study, the following
sampling techniques were overviewed:
1) Under-sampling: In random under-sampling, a subset
of samples from the majority class is selected, in order to
equal the number of samples coming from each target class.
The main disadvantage of this strategy is that potentially
relevant information from the left-out samples is lost.
2) Over-sampling: Alternatively, in random over-
sampling, minority class instances are replicated. However,
while avoiding information loss, it introduces the problem of
overfitting. By randomly copying instances, the model might
fit the training data so closely that it might not efficiently
generalize to new data. Moreover, since the model can get
the same samples for training and testing, model validation
will be no longer independent from training and this may
lead to an overestimation of the performance.
In order to overcome this limitation, Chawla et al. de-
veloped the Synthetic Minority Over-sampling TEchnique
(SMOTE) [11]. With this approach, new minority instances
are generated from the information contained in existing
minority class samples. Another similar approach that gener-
ates new synthetic instances is the Random Over-Sampling
Examples (ROSE) strategy [12], which creates new minority
class samples through smoothed bootstrapping.
D. Classification performance
In order to get realistic measures of classification perfor-
mance, the impact of each sampling strategy was measured
and compared through cross-validation (CV), independently
applying the selected sampling approach on each fold. More
specifically, a 10-times repeated 4-fold CV was applied to
train and test boosted logistic regression models [13].
Boosting algorithms have been reported to more suitably
face class imbalance problems, since they iteratively build
an ensemble of weak learners that adjust their weights to
classification results. For the first weak learner, they assign
equal weights to each sample, and for each subsequent
learner these weights are recalculated so that higher values
are assigned to previously missclassified samples. Thus,
algorithms such as AdaBoost are particularly useful in this
context since they tend to give higher weights to minority
class samples, often misclassified. In this study, logistic
regression techniques were applied to the AdaBoost method.
Furthermore, it should be noted that, in order to equalize
the contribution of all features to multivariate analysis,
variables were firstly centered and scaled. Moreover, conven-
tional classification algorithms are usually evaluated based on
the percentage of observations correctly classified (accuracy).
With imbalanced data, though, this performance metric might
not be appropriate since minority classes hold minimum
effect on overall accuracy. Thus, considering unsuccessful
cases as positives, TP : true positives, FP : false positives and
FN : false negatives, some interesting metrics when working
with imbalanced datasets are:
• Precision (P ), or positive predictive value:
P =
TP
TP + FP
(1)
• Recall (R), or Sensitivity (Se):
Recall =
TP
TP + FN
(2)
• Fβ measure, where β is usually taken as 1 (F1):
Fβ = (1 + β
2) · Recall · Precision
(β2 ·Recall) + Precision (3)
III. RESULTS
A. Statistical analysis
Figure 1 shows the results for correlation analysis, where
it can be observed that hematocrit (L1319) is positively
correlated with both hemoglobin concentration (L1314; ρ =
0.98) and red blood cell count (L1305; ρ = 0.91). The
percentage of neutrophils (L306) and lymphocytes (l308), as
well as their total amounts (L1300 and L1307), were found to
be highly correlated (ρ = −0.97 and ρ = 0.96, respectively).
Table II summarizes the mean and standard deviation for
each variable and study group, as well as the associated p-
values, when Mann-Whitney U non-parametric tests were
applied. Features showing statistically significant differences
between groups of patients are highlighted.
Since some variables were found to be highly correlated,
the application of some feature selection strategy would be
advisable in the future, in order to reduce data redundancy.
According to the results, the hematocrit could be omitted
since it shows a very strong correlation with hemoglobin
concentration, which seems to be more significant when
distinguishing between groups of patients (p-value=0.030).
Similarly, the percentage of neutrophils could be eliminated,
in favor of lymphocytes percentage (p-value=0.040). The
total amount of lymphocytes was found to be statistically
significant as well (p-value=0.023). These findings concur
with previous works where, on the one hand, lower levels
of hemoglobin concentration indicated a poor prognosis
in patients suffering from myocardial infarction [14]. On
the other hand, a higher proportion of lymphocytes in the
peripheral blood of patients suffering from different cancers,
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Fig. 1. Graphical and numerical representation of correlation results, for
variables under study (see section II.A). Positive and negative correlations
are, respectively, represented in blue and red. Numerical values are propor-
tional to color intensity and inversely proportional to ellipse widths.
TABLE II
MEAN AND STANDARD DEVIATION FOR EACH VARIABLE (SEE SECTION
II.A) AND STUDY GROUP, AND ASSOCIATED P-VALUES. ∗ : P<0.05, FOR
MANN-WHITNEY U NON-PARAMETRIC TEST.
Successful Unsuccessful p-value
(n=1850) (n=101)
L1300 9.99 ± 7.48 10.09 ± 5.75 0.727
L1301 242.95 ± 107.82 266.40 ± 146.06 0.245
L1302 8.32 ± 1.06 8.54 ± 1.28 0.194
L1305 4.10 ± 0.68 3.98 ± 0.78 0.117
L1306 74.28 ± 13.24 76.01 ± 10.92 0.278
L1307 7.54 ± 4.21 8.00 ± 5.20 0.859
L1308 15.80 ± 10.20 13.60 ± 7.58 0.040*
L1309 1.53 ± 5.02 1.14 ± 0.54 0.023*
L1310 6.76 ± 3.91 6.80 ± 3.51 0.842
L1311 0.61 ± 0.35 0.66 ± 0.59 0.998
L1312 1.97 ± 2.18 2.26 ± 2.64 0.512
L1313 0.17 ± 0.20 0.19 ± 0.21 0.317
L1314 121.69 ± 20.16 117.13 ± 21.00 0.030*
L1315 0.38 ± 0.86 0.38 ± 0.30 0.353
L1316 0.03 ± 0.28 0.02 ± 0.04 0.934
L1319 0.38 ± 0.06 0.36 ± 0.06 0.054
L1320 91.86 ± 6.51 91.72 ± 6.00 0.512
L1321 29.77 ± 2.38 29.63 ± 2.17 0.252
L1322 324.03 ± 11.62 322.94 ± 11.46 0.334
L1323 14.33 ± 1.91 14.96 ± 2.31 0.002*
L2422 137.39 ± 56.87 133.71 ± 48.39 0.595
L2467 1.03 ± 0.48 1.26 ± 0.75 0.023*
L2507 138.67 ± 3.53 138.43 ± 3.80 0.352
L2508 4.05 ± 0.50 4.15 ± 0.59 0.108
such as gastric carninomas [15], has been proposed as an
indicator of poor prognosis.
Moreover, the red cell distribution width (RDW) and
creatinine showed significant differences between groups of
patients. These results are also in line with previous works
where a higher RDW was found to be a strong independent
predictor of morbidity and mortality in heart failure [16],
and where creatinine was proposed as an indicator of bad
prognosis after different cardiac surgeries [7], [17].
B. Comparison of sampling approaches
Figure 2 shows the classification performance metrics
obtained for each applied sampling strategy.
Fig. 2. Classification performance metrics for each analyzed strategy.
As expected, the original (non-sampled) model was heav-
ily biased toward the majority class, leading to a perfect
Specificity (Sp = 1) and a Se = 0, and thus not being
able to measure P and F1. The highest Se (or R) was
obtained for the ROSE method, although at the expense of a
very low Sp. After the original model, the SMOTE method
led to the worst Se, and similar results were obtained for
random under- and over-sampling. With a slightly better P ,
but a lower Se, random over-sampling scored the highest
F1. Nevertheless, due to class imbalance, all approaches led
to very low P and thus F1 values, since TP were gained,
mostly when applying the ROSE method, at the expense of
adding a large amount of FP .
IV. CONCLUSIONS
In this study, several sampling strategies were overviewed
in order to face class imbalance, on a dataset containing the
blood test information of 1951 patients having been admitted
to a particular home-based hospitalization (HH) program.
After a first exploratory analysis, some variables, such as
hemoglobin concentration, lymphocytes and creatinine, were
found to unmask statistically significant differences between
patients undergoing successful and unsuccessful HH stays.
According to the results, blood test data is presented as
a potential complementary instrument to health conditions,
risk factors and socio-demographic information [18], in order
to identify those patients that, if proposed for HH, should
be given special attention to avoid eventual regular hospital
admissions. However, class imbalance complicates the use
of these data for the identification of unsuccessful cases.
Among the analyzed approaches, over-sampling strategies
seemed to lead to better results. The highest sensitivity was
obtained with ROSE and, according to F1, although SMOTE
and random over-sampling led to similar results, the latter
performed slightly better in this particular scenario.
This study presents an overview of the main sampling
techniques developed to face class imbalance. In order to
obtain better classification results, further improvements in
the applied machine-learning approach should be performed
in the future. Since significant correlations were noted among
variables, a feature selection step, previous to sampling,
would be advisable so as to minimize data redundancy.
Moreover, although an apparently appropriate boosted model
was implemented, different approaches should be explored to
find the best suited model configuration. Multilevel predictive
modelling including clinical, lifestyle and population data
should also be considered so as to enhance the predictive
performance of the proposed models.
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